Benzinga | Mar 25, 2021 04:09PM EDT

NovaBay Pharmaceuticals Q4 EPS $(0.04), Inline, Sales $1.89M Miss $2.48M Estimate

NovaBay Pharmaceuticals (AMEX:NBY) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 69.23 percent increase over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $1.89 million which missed the analyst consensus estimate of $2.48 million by 23.87 percent. This is a 10.80 percent increase over sales of $1.70 million the same period last year.